nimesulide has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belton, O; Byrne, D; Fitzgerald, DJ; Kearney, D; Leahy, A | 1 |
FitzGerald, GA; Li, H; Praticò, D; Tillmann, C; Zhang, ZB | 1 |
1 trial(s) available for nimesulide and 2,3-dinor-6-ketoprostaglandin f1alpha
Article | Year |
---|---|
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Humans; Isoenzymes; Macrophages; Male; Membrane Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2; Thromboxane B2 | 2000 |
1 other study(ies) available for nimesulide and 2,3-dinor-6-ketoprostaglandin f1alpha
Article | Year |
---|---|
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Artery Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Receptors, LDL; Sulfonamides; Thromboxane B2 | 2001 |